Department of Radiation Oncology (Zhang XG,Liang SX,Xu XN,Huang JH,Kou MY),Department of Image (Cheng Y),Affiliated Yuebei People’s Hospital of Shantou University Medical College,Shaoguan 512026,China; Department of Radiation Oncology,Cancer Center,Sun Yat-sen University,State Key Laboratory of Oncology in South China,Guangzhou 510060,China (Han F)
Abstract Objective To investigate the clinical features and prognostic value of primary tumor and regional lymph node necrosis in nasopharyngeal carcinoma (NPC). Methods Clinical data were collected from 477 patients newly diagnosed with NPC in our hospital from 2009 to 2013. Pretreatment MRI and CT scans of primary tumor and regional lymph nodes were performed to analyze the clinical features and prognostic value of primary tumor and regional lymph node necrosis after 3DRT. The survival rates were calculated using the Kaplan-Meier method and analyzed using the log-rank test. Univariate and multivariate prognostic analyses were made by the log-rank test and the Cox model. Results In the 477 patients, 219(45.9%) had tumor necrosis and 258(54.1%) had not. The patients without tumor necrosis had significantly longer median survival time and significantly higher 3-year overall survival (OS), progression-free survival (PFS), local recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS) rates than those with tumor necrosis (40 vs. 37 months, 93.7% vs. 78.2%, 86.7% vs. 63.8%, 96.3% vs. 87.0%, 93.4% vs. 79.7%, all P=0.000). The univariate analysis showed that tumor necrosis was an important influencing factor for OS, PFS, LRFS, and DMFS rates in patients. T stage, N stage, and clinical stage were correlated with OS, PFS, and DMFS rates in patients (P=0.000-0.004). The multivariate analysis showed that pretreatment tumor necrosis were predictive factors for all survival in patients with NPC (P=0.001-0.022),with T stage for LRFS,DMFS (P=0.016,0.006) and N stage for PFS (P=0.000). Conclusions Patients with pretreatment tumor necrosis are likely to have recurrence or metastasis as well as shorter survival time than those without tumor necrosis. On the basis of T/N stage, identification of the state of tumor necrosis helps clinical physicians to make more reasonable treatment plans and improve the prognosis.
Zhang Xiangguo,Liang Sixian,Han Fei et al. Prognostic value of pretreatment primary tumor and regional lymph node necrosis in nasopharyngeal carcinoma with 3DRT[J]. Chinese Journal of Radiation Oncology, 2016, 25(12): 1285-1289.
Zhang Xiangguo,Liang Sixian,Han Fei et al. Prognostic value of pretreatment primary tumor and regional lymph node necrosis in nasopharyngeal carcinoma with 3DRT[J]. Chinese Journal of Radiation Oncology, 2016, 25(12): 1285-1289.
[1] Chen TC,Wu CT,Wang CP,et al. Associations among pretreatment tumor necrosis and the expression of HIF-1alpha and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof[J].Oral Oncol,2015,51(11):1004-1010.10.1016/j.oraloncology.2015.08.011. [2] Park SY,Lee HS,Jang HJ,et al. Tumor necrosis as a prognostic factor for stage ⅠA non-small cell lung cancer[J].Ann Thorac Surg,2011,91(6):1668-1673.10.1016/j.athoracsur.2010.12.028. [3] Lan M,Huang Y,Chen C Y,et al. Prognostic value of cervical nodal necrosis in nasopharyngeal carcinoma:analysis of 1800 patients with positive cervical nodal metastasis at MR imaging[J].Radiology,2015,276(2):619.10.1148/radiol.15154020. [4] Chong VF,Fan YF,Khoo JB.MRI features of cervical nodal necrosis in metastatic disease[J].Clin Radiol,1996,51(2):103-109. [5] King AD,Tse GM,Ahuja AT,et al. Necrosis in metastatic neck nodes:diagnostic accuracy of CT,MR imaging,and US[J].Radiology,2004,230(3):720-726.10.1148/radiol.2303030157. [6] 高黎,易俊林,黄晓东,等.鼻咽癌根治性放疗 10年经验总结[J].中华放射肿瘤学杂志,2006,15(4):249-256.10.3760/j.issn:1004-4221.2006.04.004. Gao L,Yi JL,Huang XD,et al. Summary of 10 years′ experience in patients with nasopharyngeal carcinoma after radical radiotherapy[J].Chin J Radiat Oncol,2006,15(4):249-256.10.3760/j.issn:1004-4221.2006.04.004. [7] 王体兵,王丽君,孔诚,等.鼻咽癌调强放疗后颈淋巴结复发的临床分析[J].肿瘤学杂志,2013,19(11):862-867.10.11735/j.issn.1671-170X.2013.11.B008. Wang TB,Wang LJ,Kong CH,et al. Clinical analysis of nasopharyngeal carcinoma intensity-modulated radiotherapy for cervical lymph node recurrence[J].J Oncol,2013,19(11):862-867.10.11735/j.issn.1671-170X.2013.11.B008. [8] Zoumalan RA,Kleinberger AJ,Morris LG,et al. Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma:pilot study[J].J Laryngol Otol,2010,124(12):1284-1288.10.1017/S0022215110001453. [9] Randall DR,Lysack JT,Hudon ME,et al. Diagnostic utility of central node necrosis in predicting extracapsular spread among oral cavity squamous cell carcinoma[J].Head Neck,2015,37(1):92-96.10.1002/hed.23562. [10] Mao YP,Liang SB,Liu LZ,et al. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging[J].Clin Cancer Res,2008,14(22):7497-7503.10.1158/1078-0432.CCR-08-0271. [11] Peitzsch C,Perrin R,Hill RP,et al. Hypoxia as a biomarker for radioresistant cancer stem cells[J].Int J Radiat Biol,2014,90(8):636-652.10.3109/09553002.2014.916841. [12] Xueguan L,Xiaoshen W,Yongsheng Z,et al. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide[J].Clin Oncol (R Coll Radiol),2008,20(8):606-612.10.1016/j.clon.2008.07.001.
2016, Vol. 25 
